T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
UnitedHealth
UNH
|
$865M |
| 2 |
AbbVie
ABBV
|
$688M |
| 3 |
Intuit
INTU
|
$574M |
| 4 |
Xcel Energy
XEL
|
$466M |
| 5 |
Exelon
EXC
|
$432M |
Top Sells
| 1 |
GE Aerospace
GE
|
$974M |
| 2 |
TE Connectivity
TEL
|
$629M |
| 3 |
Equifax
EFX
|
$338M |
| 4 |
KLA
KLAC
|
$321M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$299M |
Sector Composition
| 1 | Technology | 24.86% |
| 2 | Healthcare | 22.76% |
| 3 | Financials | 12.37% |
| 4 | Consumer Discretionary | 11.76% |
| 5 | Industrials | 11.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MOR
426
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $30M | 0.02% |
7,593,135
+315,037
| +4% | +$1.24M |
|
427
Kura Oncology
KURA
$698M
| $30M | 0.02% |
2,450,031
-218,533
| -8% | -$2.67M |
|
428
Packaging Corp of America
PKG
$19.4B
| $29.8M | 0.02% |
214,865
+3,221
| +2% | +$447K |
|
429
Blue Bird Corp
BLBD
$1.82B
| $29.4M | 0.02% |
1,437,532
-249,904
| -15% | -$5.11M |
|
|
NTST
430
NETSTREIT Corp
NTST
$1.71B
| $29.1M | 0.02% |
+1,592,056
| New | +$29.1M |
|
|
VERV
431
DELISTED
Verve Therapeutics
VERV
| $28.9M | 0.02% |
2,006,127
+206,477
| +11% | +$2.98M |
|
432
Aris Water Solutions
ARIS
$788M
| $28.5M | 0.02% |
3,657,669
+42,727
| +1% | +$333K |
|
433
Equity Lifestyle Properties
ELS
$11.5B
| $28.1M | 0.02% |
418,811
+6,598
| +2% | +$443K |
|
434
Children's Place
PLCE
$114M
| $28.1M | 0.02% |
698,366
+141,161
| +25% | +$5.68M |
|
435
Capitol Federal Financial
CFFN
$835M
| $28.1M | 0.02% |
4,176,174
+450,160
| +12% | +$3.03M |
|
436
Coastal Financial
CCB
$1.72B
| $27.7M | 0.02% |
769,791
| – | – |
|
437
Vaxcyte
PCVX
$4.12B
| $27.5M | 0.02% |
733,907
+222,471
| +43% | +$8.34M |
|
438
Darling Ingredients
DAR
$5.23B
| $27.3M | 0.02% |
466,867
+7,355
| +2% | +$430K |
|
|
ICVX
439
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $27.1M | 0.02% |
4,667,385
+203,860
| +5% | +$1.18M |
|
|
CTEV
440
Claritev Corporation
CTEV
$1.14B
| $27M | 0.02% |
25,490,302
+3,171,930
| +14% | +$3.36M |
|
441
On Holding
ONON
$14.6B
| $26.8M | 0.02% |
863,547
-2,457,241
| -74% | -$76.2M |
|
|
HIBB
442
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $26.7M | 0.02% |
453,238
-337
| -0.1% | -$19.9K |
|
443
International Seaways
INSW
$2.22B
| $26.5M | 0.02% |
636,166
-120,383
| -16% | -$5.02M |
|
444
JELD-WEN Holding
JELD
$544M
| $26.4M | 0.02% |
2,086,468
-93,172
| -4% | -$1.18M |
|
445
Blue Foundry Bancorp
BLFY
$201M
| $26.2M | 0.02% |
2,756,347
-5,044
| -0.2% | -$48K |
|
446
FS Bancorp
FSBW
$320M
| $26.1M | 0.02% |
868,718
+47,291
| +6% | +$1.42M |
|
447
Cadre Holdings
CDRE
$1.26B
| $25.7M | 0.02% |
1,191,001
-13,940
| -1% | -$300K |
|
448
Xometry
XMTR
$2.6B
| $25.4M | 0.02% |
1,699,575
-806,344
| -32% | -$12.1M |
|
449
Watsco
WSO
$15.9B
| $25.4M | 0.02% |
79,720
+19,086
| +31% | +$6.07M |
|
|
INFN
450
DELISTED
Infinera Corporation Common Stock
INFN
| $25M | 0.02% |
3,219,542
+1,287,257
| +67% | +$9.99M |
|